ALSO NOTED: Nigerian state won't negotiate with Pfizer; Novartis, Sun Pharma settle Exelon patent case;

> Nigeria's Kano state has ended settlement talks with Pfizer in the much-publicized case of a disputed meningitis drug trial; state officials also asked the country's federal government for help extraditing five Americans who allegedly took part in the trial. Report

> Novartis and Sun Pharma made a deal to settle patent litigation over Sun's generic version of the dementia drug Exelon, but the specific terms weren't disclosed. Report

> Ranbaxy Laboratories got regulatory approval to make and sell the anti-HIV drug Coviro for children in India. Report

> Thailand's Food and Drug Administration has proposed heavier fines on those who make, sell, and import counterfeit meds. Report

> The U.S. FDA eased some rules governing  a program that restricts prescriptions of the Accutane acne-fighting drug to women who are proven not to be pregnant. Report

And Finally... Honey may be an effective and safe alternative than over the counter children's cough medicines, according to a Penn State College of Medicine study. Release

Suggested Articles

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

Pfizer terminated a slew of trial cohorts testing Bavencio in combination with its own experimental drugs, as well as one monotherapy trial.

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.